共 50 条
- [2] Re: Biomarkers for the Diagnosis of Prostatic Inflammation in Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2012, 188 (03): : 834 - 835
- [3] Re: Prostatic Arterial Embolization to Treat Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2012, 187 (01): : 212 - 213
- [4] Re: The Role of Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia: A Systematic Review Editorial Comment JOURNAL OF UROLOGY, 2016, 195 (01): : 138 - 138
- [5] Re: The Use of Botulinum Toxin in Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2012, 188 (03): : 896 - 896
- [6] Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2012, 188 (05): : 1846 - 1847
- [7] Re: Is Early Benign Prostatic Hyperplasia (BPH) Treatment Worthwhile? Editorial Comment JOURNAL OF UROLOGY, 2018, 200 (03): : 471 - 471
- [8] Re: Trends and Attitudes in Surgical Management of Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2012, 188 (06): : 2313 - 2314
- [9] Re: Effects of Metformin on Prostatic Tissue of Rats with Metabolic Syndrome and Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2019, 201 (04): : 640 - 640
- [10] Re: Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia Editorial Comment JOURNAL OF UROLOGY, 2018, 200 (05): : 919 - 920